Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (66)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Schwerdtle, T.
Right arrow Articles by Hartwig, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwerdtle, T.
Right arrow Articles by Hartwig, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 24, No. 5, 967-974, May 2003
© 2003 Oxford University Press


CARCINOGENESIS

Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA

Tanja Schwerdtle, Ingo Walter, Iris Mackiw and Andrea Hartwig1

Institut für Lebensmittelchemie und Toxikologie, Universität Karlsruhe, Postfach D-76128 Karlsruhe, Germany

1 To whom correspondence should be addressed Email: andrea.hartwig{at}chemie.uni-karlsruhe.de

Even though a well-known human carcinogen the underlying mechanisms of arsenic carcinogenicity are still not fully understood. For arsenite, proposed mechanisms are the interference with DNA repair processes and an increase in reactive oxygen species. Even less is known about the genotoxic potentials of its methylated metabolites monomethylarsonous [MMA(III)] and dimethylarsinous [DMA(III)] acid, monomethylarsonic [MMA(V)] and dimethylarsinic [DMA(V)] acid. Within the present study we compared the induction of oxidative DNA damage by arsenite and its methylated metabolites in cultured human cells and in isolated PM2 DNA, by frequencies of DNA strand breaks and of lesions recognized by the bacterial formamidopyrimidine–DNA glycosylase (Fpg). Only DMA(III) (>=10 µM) generated DNA strand breaks in isolated PM2 DNA. In HeLa S3 cells, short-term incubations (0.5–3 h) with doses as low as 10 nM arsenite induced high frequencies of Fpg-sensitive sites, whereas the induction of oxidative DNA damage after 18 h incubation was rather low. With respect to the methylated metabolites, both trivalent and pentavalent metabolites showed a pronounced induction of Fpg-sensitive sites in the nanomolar or micromolar concentration range, respectively, which was present after both short-term and long-term incubations. Furthermore MMA(III) and DMA(V) generated DNA strand breaks in a concentration-dependent manner. Taken together our results show that very low physiologically relevant doses of arsenite and the methylated metabolites induce high levels of oxidative DNA damage in cultured human cells. Thus, biomethylation of inorganic arsenic may be involved in inorganic arsenic-induced genotoxicity/carcinogenicity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
T. J. Jensen, P. Novak, K. E. Eblin, A. J. Gandolfi, and B. W. Futscher
Epigenetic remodeling during arsenical-induced malignant transformation
Carcinogenesis, August 1, 2008; 29(8): 1500 - 1508.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. Dopp, U. von Recklinghausen, L. M. Hartmann, I. Stueckradt, I. Pollok, S. Rabieh, L. Hao, A. Nussler, C. Katier, A. V. Hirner, et al.
Subcellular Distribution of Inorganic and Methylated Arsenic Compounds in Human Urothelial Cells and Human Hepatocytes
Drug Metab. Dispos., May 1, 2008; 36(5): 971 - 979.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Fung, P. Liu, and B. Demple
ATF4-Dependent Oxidative Induction of the DNA Repair Enzyme Ape1 Counteracts Arsenite Cytotoxicity and Suppresses Arsenite-Mediated Mutagenesis
Mol. Cell. Biol., December 15, 2007; 27(24): 8834 - 8847.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
R Colognato, F Coppede, J Ponti, E Sabbioni, and L Migliore
Genotoxicity induced by arsenic compounds in peripheral human lymphocytes analysed by cytokinesis-block micronucleus assay
Mutagenesis, July 1, 2007; 22(4): 255 - 261.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
Y.-S. Pu, K.-Y. Jan, T.-C. Wang, A. S. S. Wang, and J.-R. Gurr
8-Oxoguanine DNA Glycosylase and MutY Homolog Are Involved in the Incision of Arsenite-Induced DNA Adducts
Toxicol. Sci., February 1, 2007; 95(2): 376 - 382.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. A. Zykova, F. Zhu, C. Lu, L. Higgins, Y. Tatsumi, Y. Abe, A. M. Bode, and Z. Dong
Lymphokine-Activated Killer T-Cell-Originated Protein Kinase Phosphorylation of Histone H2AX Prevents Arsenite-Induced Apoptosis in RPMI7951 Melanoma Cells
Clin. Cancer Res., December 1, 2006; 12(23): 6884 - 6893.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. Dopp, L. M. Hartmann, U. von Recklinghausen, A. M. Florea, S. Rabieh, U. Zimmermann, B. Shokouhi, S. Yadav, A. V. Hirner, and A. W. Rettenmeier
Forced Uptake of Trivalent and Pentavalent Methylated and Inorganic Arsenic and Its Cyto-/genotoxicity in Fibroblasts and Hepatoma Cells
Toxicol. Sci., September 1, 2005; 87(1): 46 - 56.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
M. A. Rodriguez-Gabriel and P. Russell
Distinct Signaling Pathways Respond to Arsenite and Reactive Oxygen Species in Schizosaccharomyces pombe
Eukaryot. Cell, August 1, 2005; 4(8): 1396 - 1402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Nuntharatanapong, K. Chen, P. Sinhaseni, and J. F. Keaney Jr.
EGF receptor-dependent JNK activation is involved in arsenite-induced p21Cip1/Waf1 upregulation and endothelial apoptosis
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H99 - H107.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W.-C. Chou, H.-Y. Chen, S.-L. Yu, L. Cheng, P.-C. Yang, and C. V. Dang
Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation
Blood, July 1, 2005; 106(1): 304 - 310.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. A. Bonzo, S. Chen, A. Galijatovic, and R. H. Tukey
Arsenite Inhibition of CYP1A1 Induction by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Independent of Cell Cycle Arrest
Mol. Pharmacol., April 1, 2005; 67(4): 1247 - 1256.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L.-H. Yih, S.-W. Hsueh, W.-S. Luu, T. H. Chiu, and T.-C. Lee
Arsenite induces prominent mitotic arrest via inhibition of G2 checkpoint activation in CGL-2 cells
Carcinogenesis, January 1, 2005; 26(1): 53 - 63.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Sordet, Z. Liao, H. Liu, S. Antony, E. V. Stevens, G. Kohlhagen, H. Fu, and Y. Pommier
Topoisomerase I-DNA Complexes Contribute to Arsenic Trioxide-induced Apoptosis
J. Biol. Chem., August 6, 2004; 279(32): 33968 - 33975.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
E. Guillamet, A. Creus, J. Ponti, E. Sabbioni, S. Fortaner, and R. Marcos
In vitro DNA damage by arsenic compounds in a human lymphoblastoid cell line (TK6) assessed by the alkaline Comet assay
Mutagenesis, March 1, 2004; 19(2): 129 - 135.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.